Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis
- PMID: 31238898
- PMCID: PMC6593509
- DOI: 10.1186/s12882-019-1421-z
Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis
Abstract
Background: Maintenance dialysis is a costly and resource intense activity. In Australia, inadequate health infrastructure and poor access to technically skilled staff can limit service provision in remote areas where many Aboriginal dialysis patients live. With most studies based on urban service provision, there is little evidence to guide service development. However permanent relocation to an urban area for treatment can have significant social and financial impacts that are poorly quantified. This study is part of a broader project to quantify the costs and benefits of dialysis service models in urban and remote locations in Australia's Northern Territory (NT).
Methods: We undertook a micro-costing analysis of dialysis service delivery costs in urban, rural and remote areas in the NT from the payer perspective. Recurrent maintenance costs (salaries, consumables, facility management and transportation) as well as capital costs were included. Missing and centralised costs were standardised; results were inflated to 2017 values and reported in Australian dollars.
Results: There was little difference between the average annual cost for urban and rural services with respective median costs of $85,919 versus $84,629. However remote service costs were higher ($120,172 - $124,492), driven by higher staff costs. The inclusion of capital costs did not add substantially to annual costs. Annual home haemodialysis costs ($42,927) were similar to other jurisdictions despite the significant differences in program delivery and payment of expenses not traditionally borne by governments. Annual peritoneal dialysis costs ($58,489) were both higher than home and in-centre haemodialysis by recent national dialysis cost studies.
Conclusion: The cost drivers for staffed services were staffing models and patient attendance rates. Staff salaries and transport costs were significantly higher in remote models of care. Opportunities to reduce expenditure exist by encouraging community supported services and employing local staff. Despite the delivery challenges of home haemodialysis including high patient attrition, the program still provides a cost benefit compared to urban staffed services. The next component of this study will examine patient health service utilisation and costs by model of care to provide a more comprehensive analysis of the overall cost of providing services in each location.
Keywords: Aboriginal; Costs; Dialysis; Expenditure; Remote; Rural.
Conflict of interest statement
AC is Chair of the Australian Department Medicare Benefits Schedule (MBS) Review Renal Medicine Clinical Committee.
KH is a member of the Australian Department Medicare Benefits Schedule (MBS) Review Renal Medicine Clinical Committee.
Figures




Similar articles
-
Do remote dialysis services really cost more? An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settings.BMC Health Serv Res. 2021 Jun 17;21(1):582. doi: 10.1186/s12913-021-06612-z. BMC Health Serv Res. 2021. PMID: 34140001 Free PMC article.
-
Dialysis attendance patterns and health care utilisation of Aboriginal patients attending dialysis services in urban, rural and remote locations.BMC Health Serv Res. 2022 Feb 24;22(1):251. doi: 10.1186/s12913-022-07628-9. BMC Health Serv Res. 2022. PMID: 35209888 Free PMC article.
-
Cost impact of high staff turnover on primary care in remote Australia.Aust Health Rev. 2019 Jan;43(6):689-695. doi: 10.1071/AH17262. Aust Health Rev. 2019. PMID: 30158049
-
Cardiac rehabilitation services for people in rural and remote areas: an integrative literature review.Rural Remote Health. 2018 Nov;18(4):4738. doi: 10.22605/RRH4738. Epub 2018 Nov 7. Rural Remote Health. 2018. PMID: 30403491 Review.
-
Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations.Appl Health Econ Health Policy. 2019 Jun;17(3):315-330. doi: 10.1007/s40258-018-00455-2. Appl Health Econ Health Policy. 2019. PMID: 30714086
Cited by
-
Health professional experiences of kidney transplantation in regional, rural, and remote Australia.BMC Nephrol. 2025 Feb 20;26(1):88. doi: 10.1186/s12882-025-04015-4. BMC Nephrol. 2025. PMID: 39979874 Free PMC article.
-
Effect of interdisciplinary obesity care on metabolic markers and body weight in people with type 2 diabetes in a rural setting: A randomised controlled trial.Clin Obes. 2025 Apr;15(2):e12715. doi: 10.1111/cob.12715. Epub 2024 Nov 7. Clin Obes. 2025. PMID: 39511718 Free PMC article. Clinical Trial.
-
Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.BMC Health Serv Res. 2024 Jul 9;24(1):791. doi: 10.1186/s12913-024-11258-8. BMC Health Serv Res. 2024. PMID: 38982437 Free PMC article.
-
Developing an integrated clinical decision support system for the early identification and management of kidney disease-building cross-sectoral partnerships.BMC Med Inform Decis Mak. 2024 Mar 8;24(1):69. doi: 10.1186/s12911-024-02471-w. BMC Med Inform Decis Mak. 2024. PMID: 38459531 Free PMC article.
-
Impact of COVID-19 on the worsening crisis of chronic kidney disease: the imperative to fund early detection is now.Intern Med J. 2022 Apr;52(4):680-682. doi: 10.1111/imj.15670. Epub 2022 Mar 6. Intern Med J. 2022. PMID: 35249248 Free PMC article.
References
-
- Australian Institute of Health and Welfare . In: Chronic kidney disease: regional variation in Australia. AIHW, editor. Canberra: Australian Government; 2013.
-
- ANZDATA Registry . 40th Report, Chapter 2: Prevalence of Renal Replacement Therapy for End Stage Kidney Disease Adelaide Australia: Australia and New Zealand Dialysis and Transplant Registry. 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials